Alzheimer's Disease Neuroimaging Initiative (ADNI 4)
| Study Name | Alzheimer's Disease Neuroimaging Initiative (ADNI 4) |
| Principal Investigator(s) | James Brewer, M.D., Ph.D. |
| Description |
The Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI 4) is a 5-year study designed to engage diverse participants to ensure that ADRD research represents all people. This includes Black, Latino/Hispanic, Asian, Pacific Islander/Native Hawaiian, and American Indian/Alaska Native participants. The primary goal of ADNI 4 is to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in ongoing Alzheimer’s disease research. ADNI plays a central role in improving treatment trials and is a non-randomized, natural history, non-treatment study. |
| Required Diagnosis | Normal Cognition, Mild Cognitive Impairment (MCI), Alzheimer's disease (AD) |
| Age | 55-90 |
| Length | Minimum 5 years |
| Lumbar Puncture | Not required |
| MRI | Yes |
| Amyloid PET | Yes |
| Tau PET | Yes |
| Compensation | Yes for time and travel |
| Contact |
Jen Frascino: jfrascino@health.ucsd.edu |
| For More Information: | https://www.adni4.org/about-the-study/ |